Fulton Bank’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$884K Sell
4,172
-102
-2% -$20K 0.03% 351
2026
Q1
$838K Buy
4,274
+94
+2% +$18.3K 0.03% 342
2025
Q4
$725K Buy
4,180
+68
+2% +$12.4K 0.03% 355
2025
Q3
$784K Buy
4,112
+752
+22% +$133K 0.03% 338
2025
Q2
$604K Buy
3,360
+767
+30% +$133K 0.02% 385
2025
Q1
$439K Buy
+2,593
New +$426K 0.02% 439
2020
Q1
Sell
-2,617
Closed -$279K 391
2019
Q4
$279K Sell
2,617
-1,605
-38% -$167K 0.02% 358
2019
Q3
$452K Buy
4,222
+6
+0.1% +$616 0.03% 263
2019
Q2
$429K Buy
+4,216
New +$405K 0.03% 274

Other funds holding DGX

Fulton Bank's DGX Position: Q2 2026 in Review

Fulton Bank reduced its Quest Diagnostics (DGX) stake by 2.4% in Q2 2026, selling an estimated $20K and leaving 4,172 shares worth $884K. The position accounts for 0.03% of the portfolio, ranked #351.

Fulton Bank first reported a position in DGX in Q2 2019 and has held it in 9 quarters since. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Fulton Bank held 4,172 shares of Quest Diagnostics worth $884K as of Q2 2026.
  • Fulton Bank sold 102 Quest Diagnostics shares in Q2 2026, an estimated $20K.
  • Quest Diagnostics made up 0.03% of Fulton Bank's portfolio in Q2 2026, its #351 holding.
  • Fulton Bank first reported a position in Quest Diagnostics in Q2 2019 and has held it in 9 quarters since.
  • 1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Fulton Bank's 13F filing for Q2 2026, filed 9 Jul 2026.